Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/13/2026

Imaging and Referral Guidelines for Adolescents with Prolonged Menstrual Bleeding

Assessment of Medication Use and Sexual Activity

  • Review current medications—including anticoagulants, hormonal contraceptives, and other agents that affect bleeding—to identify iatrogenic contributors to prolonged menses. CDC MMWR Recommendations advise this as a standard component of the history. 1
  • Determine the patient’s sexual activity status to evaluate pregnancy risk and the need for sexually transmitted infection screening when investigating prolonged menstrual bleeding. CDC MMWR Recommendations list this as a key history element. 2

Indications for Pelvic Imaging

  • Pelvic imaging is not routinely required in adolescents with prolonged menses unless a palpable pelvic mass is detected on physical examination. American College of Radiology guidelines specify this as a trigger for imaging. 3
  • Imaging is also indicated when the adolescent presents with severe pelvic pain suggestive of an underlying structural pathology, per American College of Radiology recommendations. 3

Choice of Ultrasound Modality

  • When imaging is clinically indicated, transvaginal ultrasound is the first‑line modality for sexually active adolescents, whereas transabdominal ultrasound is preferred for those who are not sexually active. This approach is endorsed by the American College of Radiology. 3

Endometrial Biopsy Considerations

  • Routine endometrial biopsy is not indicated in adolescents with prolonged menstrual bleeding because endometrial cancer is exceedingly rare in this age group. The American College of Radiology advises against biopsy except for highly unusual circumstances. 3

Referral Criteria

  • Gynecology referral is recommended when a structural abnormality is identified on imaging studies, according to American College of Radiology guidance. 3

Contraceptive‑Related Bleeding

  • In adolescents using depot medroxyprogesterone acetate (DMPA), contraceptive implants, or intrauterine devices (IUDs), clinicians should consider medication‑related bleeding patterns while still ruling out pregnancy, sexually transmitted infections, and other new pathologic conditions. This recommendation is outlined in CDC MMWR Recommendations. 4

Evidence‑Based Guidelines for Evaluating and Managing Irregular Menstrual Bleeding in Adolescents

Definition of Irregular Menstrual Cycles

Clinical Examination Recommendations

Routine Physical Examination

Avoidance of Unnecessary Pelvic Exams

Laboratory Evaluation

Mandatory Pregnancy Testing

Thyroid Function Assessment

Referral Criteria

Gynecology Referral

Management Pitfalls to Avoid

Hormonal Therapy Initiation

Evidence‑Based Management of Irregular Menstruation with Blood Clots

Diagnostic and Initial Assessment

Acute Medical Management

Long‑Term Maintenance Therapy

Contraceptive‑Related Bleeding Strategies

Referral and Escalation Criteria

Safety and Contraindication Alerts

All statements are supported by the cited guideline sources; strength of evidence was not explicitly graded in the source documents.